Medications
Wegovy Price Drop: New Lower Prices from March 2026
Novo Nordisk has reduced Wegovy starting dose prices. New RRP from $370/month for the 0.25 mg dose.
Well Revolution
March 2, 2026
Novo Nordisk has announced reduced recommended retail prices for starting and escalation doses of Wegovy (semaglutide). The new pricing takes effect from 16 March 2026 and makes it significantly cheaper to begin treatment.
New Wegovy Pricing from 16 March 2026
The updated recommended retail prices (RRP) introduce dose-dependent pricing for Wegovy for the first time. Previously, Wegovy cost a flat rate of $460 to $500 per month regardless of dose. Under the new pricing, starting and escalation doses are considerably cheaper.
These are Novo Nordisk's recommended retail prices inclusive of GST. Actual prices may vary between pharmacies and do not include dispensing fees, consultation fees, or other service charges.
What This Means for Your Costs
The biggest savings are during the first four months of treatment. Here's how the new pricing compares to what patients were previously paying:
- Month 1 (0.25 mg): Now $370, previously $460-$500. A saving of up to $130.
- Month 2 (0.5 mg): Now $390, previously $460-$500. A saving of up to $110.
- Month 3 (1.0 mg): Now $410, previously $460-$500. A saving of up to $90.
- Month 4 (1.7 mg): Now $455, previously $460-$500. A saving of up to $45.
- Month 5 onwards (2.4 mg): $475, which falls within the previous price range.
Over the first four months of titration, you could save up to $375 compared to previous pricing. This makes it more affordable to start treatment and work through the dose escalation schedule.
Why Are Prices Coming Down?
Novo Nordisk cited the need to improve affordability and access, noting that more than two-thirds (66.9%) of adults are living with overweight or obesity. The price reduction comes shortly after the launch of Mounjaro (tirzepatide), a competing weight loss medication that became available in early 2026.
Wegovy remains unfunded by PHARMAC, meaning patients pay the full cost privately. The reduced starting prices help lower the barrier to beginning treatment.
How Wegovy Now Compares to Mounjaro
With the new pricing, Wegovy's starting doses are now cheaper than Mounjaro's. Here's how the two medications compare on cost:
Wegovy is now the more affordable option at every stage of treatment. However, cost is only one factor. Mounjaro's dual-action mechanism (targeting both GIP and GLP-1 receptors) has shown greater average weight loss in clinical trials: 20-22% with Mounjaro compared to approximately 15% with Wegovy. The right choice depends on your individual goals, budget, and how you respond to treatment.
For a detailed comparison, read our guides
- Mounjaro vs Wegovy Cost Comparison: Which Is Better Value?
- Mounjaro vs Wegovy: Which Weight Loss Injection is Right for You?
When Do the New Prices Take Effect?
The new recommended retail prices take effect from 16 March 2026. If you're currently on Wegovy, your pharmacy should reflect the updated pricing from this date. If you're on a starting or escalation dose, you should see an immediate reduction in your monthly cost.
If you're considering starting treatment, the reduced prices make March 2026 an excellent time to begin. The first month of Wegovy at $370 is the lowest entry point for prescription weight loss medication currently available.
Getting Started with Wegovy
Wegovy requires a prescription from a registered doctor. You may be eligible if you have a BMI of 30 or above, or a BMI of 27 or above with a weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes.
At Well Revolution, we offer free initial consultations to assess your eligibility. Our chat-based GP service provides prescriptions, repeats, and unlimited same-day support, seven days a week, all without appointments.
Seeing a doctor is as easy as sending a text
Concerned, need advice, a prescription, refill or referral?
Chat with a GP now
Subscribe to our newsletter
